Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ICER Posts Draft Scoping Document for the Assessment of Treatments for Duchenne Muscular Dystrophy

firstwordpharmaJanuary 13, 2019

Tag: treatments , Duchenne Muscular Dystrophy , ICER , treatments

PharmaSources Customer Service